205. O’Keefe J.H., Patil H.R., Lavie C.J. et al. Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc. 2012 Jun;87(6):587-95. doi: 10.1016/j.mayocp.2012.04.005. www.ncbi.nlm.nih.gov/pubmed/22677079 (дата обращения: 28.01.2021).
206. Fedintsev A., Moskalev A. Stochastic non-enzymatic modification of long-lived macromolecules – A missing hallmark of aging. Ageing Res Rev. 2020 Sep;62:101097. doi: 10.1016/j.arr.2020.101097. www.ncbi.nlm.nih.gov/pubmed/32540391 (дата обращения: 28.01.2021).
207. Monnier V.M., Sell D.R. Prevention and repair of protein damage by the Maillard reaction in vivo. Rejuvenation Res. Summer 2006;9(2):264-73. doi: 10.1089/ rej.2006.9.264. www.ncbi.nlm.nih.gov/pubmed/16706654 (дата обращения: 28.01.2021).
208. Eekhoff J.D., Fang F., Lake S.P. Multiscale mechanical effects of native collagen cross-linking in tendon. Connect Tissue Res. 2018 Sep;59(5):410–422. doi: 10.1080/03008207.2018.1449837. www.ncbi.nlm.nih.gov/pubmed/29873266 (дата обращения: 28.01.2021).
209. Biemel K.M., Friedl D.A., Lederer M.O. Identification and quantification of major maillard cross-links in human serum albumin and lens protein. Evidence for glucosepane as the dominant compound. J Biol Chem. 2002 Jul 12;277(28):24907-15. doi: 10.1074/jbc. M202681200. www.ncbi.nlm.nih.gov/pubmed/11978796 (дата обращения: 28.01.2021).
210. Narayan K.M., Boyle J.P., Thompson T.J. et al. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003 Oct 8;290(14):1884-90. doi: 10.1001/jama.290.14.1884. www.ncbi.nlm.nih.gov/pubmed/14532317 (дата обращения: 28.01.2021).
211. Bannister C.A., Holden S.E., Jenkins-Jones S. et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab. 2014 Nov;16(11):1165-73. doi: 10.1111/dom.12354. www.ncbi. nlm.nih.gov/pubmed/25041462 (дата обращения: 28.01.2021).
212. Monnier V.M., Wu X. Enzymatic deglycation with amadoriase enzymes from Aspergillus sp. as a potential strategy against the complications of diabetes and aging. Biochem Soc Trans. 2003 Dec;31(Pt 6):1349-53. doi: 10.1042/bst0311349. www.ncbi. nlm.nih.gov/pubmed/14641061 (дата обращения: 28.01.2021).
213. Veiga da-Cunha M., Jacquemin P., Delpierre G. et al. Increased protein glycation in fructosamine 3-kinase-deficient mice. Biochem J. 2006 Oct 15;399(2):257-64. doi: 10.1042/BJ20060684. www.ncbi.nlm.nih.gov/pubmed/16819943 (дата обращения: 28.01.2021).
214. Van Schaftingen E., Collard F., Wiame E., Veiga-da-Cunha M. Enzymatic repair of Amadori products. Amino Acids. 2012 Apr;42(4):1143-50. doi: 10.1007/s00726-010-0780-3. www.ncbi.nlm.nih.gov/pubmed/20967558 (дата обращения: 28.01.2021).
215. Исследование на фруктозамин: показания. (Электронный ресурс) URL: https://gidanaliz.ru/analiz/biohim/fruktozamin.html (дата обращения: 28.01.2021).
216. Wolever T.M., Jenkins D.J., Vuksan V. et al. Beneficial effect of low-glycemic index diet in overweight NIDDM subjects. Diabetes Care. 1992 Apr;15(4):562-4. doi: 10.2337/diacare.15.4.562. www.ncbi.nlm.nih.gov/pubmed/1499480 (дата обращения: 28.01.2021).
217. Franz M.J. The argument against glycemic index: what are the other options? Nestle Nutr Workshop Ser Clin Perform Programme. 2006;11:57–72. doi: 10.1159/000094406. www.ncbi.nlm.nih.gov/pubmed/16820731 (дата обращения: 28.01.2021).
218. Szwergold B.S. Carnosine and anserine act as effective transglycating agents in decomposition of aldose-derived Schiff bases. Biochem Biophys Res Commun. 2005 Oct 14;336(1):36–41. doi: 10.1016/j.bbrc.2005.08.033. www.ncbi.nlm.nih.gov/ pubmed/16112643 (дата обращения: 28.01.2021).
219. Vistoli G., De Maddis D., Cipak A. et al. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res. 2013 Aug;47 Suppl 1:3-27. doi: 10.3109/10715762.2013.815348. www.ncbi.nlm. nih.gov/pubmed/23767955 (дата обращения: 28.01.2021).
220. Lombardi C., Carubelli V., Lazzarini V. et al. Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. Nutrition. 2015 Jan;31(1):72-8. doi: 10.1016/j. nut.2014.04.021. www.ncbi.nlm.nih.gov/pubmed/25287762 (дата обращения: 28.01.2021).
221. Stote K.S., Wilson M.M., Hallenbeck D. et al. Effect of Blueberry Consumption on Cardiometabolic Health Parameters in Men with Type 2 Diabetes: An 8-Week, DoubleBlind, Randomized, Placebo-Controlled Trial. Curr Dev Nutr. 2020 Mar 9;4(4):nzaa030. doi: 10.1093/cdn/nzaa030. www.ncbi.nlm.nih.gov/pubmed/32337475 (дата обращения: 28.01.2021).
222. Alehagen U., Johansson P., Bj rnstedt M. et al. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. Int J Cardiol. 2013 Sep 1;167(5):1860-6. doi: 10.1016/j.ijcard.2012.04.156. www.ncbi.nlm.nih.gov/pubmed/22626835 (дата обращения: 28.01.2021).
223. Wu X., Monnier V.M. Enzymatic deglycation of proteins. Arch Biochem Biophys. 2003 Nov 1;419(1):16–24. doi: 10.1016/j.abb.2003.08.011. www.ncbi.nlm.nih.gov/ pubmed/14568004 (дата обращения: 28.01.2021).
224. Sell D.R., Lapolla A., Odetti P. et al. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes. 1992 Oct;41(10):1286-92. doi: 10.2337/diab.41.10.1286. www.ncbi.nlm.nih.gov/ pubmed/1397702 (дата обращения: 28.01.2021).
225. DeGroot J., Verzijl N., Bank R.A. et al. Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation. Arthritis Rheum. 1999 May;42(5):1003-9. doi: 10.1002/1529-0131(199905)42:5<1003::AID-ANR20>3.0.CO;2-K. www.ncbi.nlm.nih.gov/pubmed/10323457 (дата обращения: 28.01.2021).
226. Sasaki N., Fukatsu R., Tsuzuki K. et al. Advanced glycation end products in Alzheimer’s disease and other neurodegenerative diseases. Am J Pathol. 1998 Oct;153(4):1149-55. doi: 10.1016/S0002-9440(10)65659-3. www.ncbi.nlm.nih.gov/ pubmed/9777946 (дата обращения: 28.01.2021).
227. Baynes J.W., Thorpe S.R. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med. 2000 Jun 15;28(12):1708-16. doi: 10.1016/s0891-5849(00)00228-8. www.ncbi.nlm.nih.gov/pubmed/10946212 (дата обращения: 28.01.2021).
228. Madsen H., Ditzel J. Blood-oxygen transport in first trimester of diabetic pregnancy. Acta Obstet Gynecol Scand. 1984;63(4):317-20. doi: 10.3109/00016348409155523. www.ncbi.nlm.nih.gov/pubmed/6741458 (дата обращения: 28.01.2021).
229. Metcalf P.A., Kyle C., Kenealy T., Jackson R.T. HbA 1c in relation to incident diabetes and diabetes-related complications in non-diabetic adults at baseline. J Diabetes Complications. 2017 May;31(5):814–823. doi: 10.1016/j.jdiacomp.2017.02.007. www. ncbi.nlm.nih.gov/pubmed/28319002 (дата обращения: 28.01.2021).
230. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care. 2014 Jan;37 Suppl 1:S14-80. doi: 10.2337/dc14-S014. www.ncbi.nlm. nih.gov/pubmed/24357209 (дата обращения: 28.01.2021).
231. Huang Y., Cai X., Mai W. et al. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016 Nov 23;355:i5953. doi: 10.1136/bmj.i5953. www.ncbi.nlm.nih.gov/ pubmed/27881363 (дата обращения: 28.01.2021).
232. Margolis K.L., O’Connor P.J., Morgan T.M. et al. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial. Diabetes Care. 2014 Jun;37(6):1721-8. doi: 10.2337/dc13-2334. www. ncbi.nlm.nih.gov/pubmed/24595629 (дата обращения: 28.01.2021).
233. Fang H.J., Zhou Y.H., Tian Y.J. et al. Effects of intensive glucose lowering in treatment of type 2 diabetes mellitus on cardiovascular outcomes: A meta-analysis of data from 58,160 patients in 13 randomized controlled trials. Int J Cardiol. 2016 Sep 1;218:50–58. doi: 10.1016/j.ijcard.2016.04.163. www.ncbi.nlm.nih.gov/pubmed/27236108 (дата обращения: 28.01.2021).
234. Campbell J.M., Bellman S.M., Stephenson M.D., Lisy K. Metformin reduces allcause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis. Ageing Res Rev. 2017 Nov;40:31–44. doi: 10.1016/j.arr.2017.08.003. www.ncbi.nlm.nih.gov/pubmed/28802803 (дата обращения: 28.01.2021).
235. Svensson E., Baggesen L.M., Johnsen S.P. et al. Early Glycemic Control and Magnitude of HbA 1c Reduction Predict Cardiovascular Events and Mortality: PopulationBased Cohort Study of 24,752 Metformin Initiators. Diabetes Care. 2017 Jun;40(6):800–807. doi: 10.2337/dc16-2271. www.ncbi.nlm.nih.gov/pubmed/28404659 (дата обращения: 28.01.2021).
236. Diabetes Prevention Program Research Group, Knowler W.C., Fowler S.E., Hamman R.F. et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009 Nov 14;374(9702):1677-86. doi: 10.1016/S0140-6736(09)61457-4. www.ncbi.nlm.nih.gov/pubmed/19878986 (дата обращения: 28.01.2021).
237. Salpeter S.R., Buckley N.S., Kahn J.A., Salpeter E.E. Meta-analysis: metformin treatment in persons at risk for diabetes mellitus. Am J Med. 2008 Feb;121(2):149–157. e2. doi: 10.1016/j.amjmed.2007.09.016. www.ncbi.nlm.nih.gov/pubmed/18261504 (дата обращения: 28.01.2021).
238. Walton R.G., Dungan C.M., Long D.E. et al. Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double-blind, placebo-controlled, multicenter trial: The MASTERS trial. Aging Cell. 2019 Dec;18(6):e13039. doi: 10.1111/acel.13039. www.ncbi.nlm.nih.gov/pubmed/31557380 (дат